ResearchMoz presents professional and in-depth study of "The Global Market for Pain Management Drugs and Devices".
Report Highlights
The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377214
Report Includes
An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
Examination of product categories, use of products, and the competitive landscape
Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
Discussion of new regulatory requirements
Comprehensive company profiles of major players in the industry
Report Scope
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.
The report identifies two general segments of pain management:
Pharmaceuticals.
Devices.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/the-global-market-for-pain-management-drugs-and-devices-report.html/toc
Within the pharmaceuticals segment several sub-segments are discussed in detail including:
Narcotic pain management.
Non-narcotic pain management.
Antimigraine treatments.
Anesthetics.
Other drugs (including CNS therapies).
The device segment covers several product lines and specifically targets the largest product segments including:
Electrotherapy stimulators.
Spine stimulators.
Other products (including electromagnetic therapies and other treatments).
Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.
Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.
A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:
Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
Celebrex : Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377214
The report is also evaluated in terms of application, discussing market trends and performance for the following areas:
Surgical pain.
Orthopedic/musculoskeletal pain.
Migraine pain.
Fibromyalgia pain.
Cancer pain.
Neuropathic pain.
HIV/AIDS pain.
Dental pain.
General pain.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Report Highlights
The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377214
Report Includes
An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
Examination of product categories, use of products, and the competitive landscape
Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
Discussion of new regulatory requirements
Comprehensive company profiles of major players in the industry
Report Scope
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.
The report identifies two general segments of pain management:
Pharmaceuticals.
Devices.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/the-global-market-for-pain-management-drugs-and-devices-report.html/toc
Within the pharmaceuticals segment several sub-segments are discussed in detail including:
Narcotic pain management.
Non-narcotic pain management.
Antimigraine treatments.
Anesthetics.
Other drugs (including CNS therapies).
The device segment covers several product lines and specifically targets the largest product segments including:
Electrotherapy stimulators.
Spine stimulators.
Other products (including electromagnetic therapies and other treatments).
Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.
Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.
A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:
Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
Celebrex : Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377214
The report is also evaluated in terms of application, discussing market trends and performance for the following areas:
Surgical pain.
Orthopedic/musculoskeletal pain.
Migraine pain.
Fibromyalgia pain.
Cancer pain.
Neuropathic pain.
HIV/AIDS pain.
Dental pain.
General pain.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment